Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Dermatomyositis (DM)”

25 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 25 results

Testing effectiveness (Phase 2)Study completedNCT04628936
What this trial is testing

Open-label Extension to the Phase 2 Crossover Study (PRESIDIO) Evaluating KZR-616 in Patients With PM and DM.

Who this might be right for
PolymyositisDermatomyositis
Kezar Life Sciences, Inc. 18
Testing effectiveness (Phase 2)Study completedNCT05669014
What this trial is testing

Proof of Concept Study to Evaluate the Efficacy and Safety of Daxdilimab in Participants With Dermatomyositis (DM) or Anti-synthetase Inflammatory Myositis (ASIM)

Who this might be right for
Idiopathic Inflammatory Myositis
Amgen 12
Large-scale testing (Phase 3)Ended earlyNCT04999020
What this trial is testing

Ravulizumab Versus Placebo in Adult Participants With Dermatomyositis

Who this might be right for
Dermatomyositis
Alexion Pharmaceuticals, Inc. 38
Testing effectiveness (Phase 2)Looking for participantsNCT07111065
What this trial is testing

FAST for DM - Fatty Acid Supplementation Trial (FAST) for Dermatomyositis (DM)

Who this might be right for
Dermatomyositis (DM)Juvenile Dermatomyositis (JDM)
National Institute of Environmental Health Sciences (NIEHS) 300
Large-scale testing (Phase 3)UnknownNCT03857854
What this trial is testing

Efficacy and Safety of Pirfenidone in Patient With Dermatomyositis Interstitial Lung Disease (Dm-ILD)

Who this might be right for
Dermatomyositis Interstitial Lung Disease (Dm-ILD)
Beijing Continent Pharmaceutical Co, Ltd. 152
Testing effectiveness (Phase 2)Study completedNCT00106184
What this trial is testing

Rituximab for the Treatment of Refractory Adult and Juvenile Dermatomyositis (DM) and Adult Polymyositis (PM)

Who this might be right for
MyositisDermatomyositisPolymyositis+1 more
University of Pittsburgh 200
Large-scale testing (Phase 3)Study completedNCT00335985
What this trial is testing

Efficacy and Safety Study of GB-0998 for Treatment of Steroid-resistant Polymyositis and Dermatomyositis (PM/DM)

Who this might be right for
PolymyositisDermatomyositis
Japan Blood Products Organization 26
Post-approval studies (Phase 4)UnknownNCT01151644
What this trial is testing

Safety and Efficacy of Anti-Pandemic H1N1 Vaccination in Rheumatic Diseases

Who this might be right for
Rheumatoid ArthritisSpondyloarthritisSystemic Lupus Erythematosus (SLE)+9 more
University of Sao Paulo 5,000
Not applicableActive Not RecruitingNCT07531446
What this trial is testing

Construction of a Clinico-Imaging Collaborative Diagnostic Model for Dermatomyositis Combined With Interstitial Lung Disease Based on PET/CT Imaging Features and Clinical Parameters

Who this might be right for
Dermatomyositis (DM)ILDMachine Learning+1 more
Ruijin Hospital 200
Very early researchStudy completedNCT04723303
What this trial is testing

Phase 1 Study of ULSC in Patients With Polymyositis (PM) and Dermatomyositis (DM)

Who this might be right for
PolymyositisDermatomyositis
University of Florida 10
Not applicableUnknownNCT05637931
What this trial is testing

Plexin D1 as a Potential Biomarker inPM/DM

Who this might be right for
PolymyositisDermatomyositis
Assiut University 66
Large-scale testing (Phase 3)Study completedNCT00651040
What this trial is testing

Combined Treatment of Methotrexate + Glucocorticoids Versus Glucocorticoids Alone in Patients With PM and DM

Who this might be right for
PolymyositisDermatomyositis
Institute of Rheumatology, Prague 31
Large-scale testing (Phase 3)Looking for participantsNCT05895786
What this trial is testing

Understand How the Study Medicine (PF-06823859) Works in People With Active Idiopathic Inflammatory Myopathies [Dermatomyositis (DM) and Polymyositis (PM)]

Who this might be right for
Myositis
Pfizer 318
Not applicableStudy completedNCT03414086
What this trial is testing

Predictor of Clinical Response to Acthar in Myositis

Who this might be right for
MyositisDermatomyositisPolymyositis
University of Pittsburgh 20
Early research (Phase 1)Enrolling By InvitationNCT06723106
What this trial is testing

Phase 1b Long-term Extension Trial of RAY121 in Immunological Diseases (RAINBOW-LTE Trial)

Who this might be right for
Antiphospholipid Syndrome (APS)Bullous Pemphigoid (BP)Behçet's Syndrome (BS)+3 more
Chugai Pharmaceutical 144
Not applicableLooking for participantsNCT07265999
What this trial is testing

Severity Factors of Dermatomyositis in the Caribbean Population - DM-ANTILLES

Who this might be right for
Dermatomyositis
Centre Hospitalier Universitaire de la Guadeloupe 10
Early research (Phase 1)Looking for participantsNCT06371417
What this trial is testing

Phase 1b Trial of RAY121 in Immunological Diseases (RAINBOW Trial)

Who this might be right for
Antiphospholipid Syndrome (APS)Bullous Pemphigoid (BP)Behçet's Syndrome (BS)+3 more
Chugai Pharmaceutical 144
Testing effectiveness (Phase 2)Ended earlyNCT02029274
What this trial is testing

Safety and Efficacy of BAF312 in Dermatomyositis

Who this might be right for
Active Dermatomyositis
Novartis Pharmaceuticals 17
Large-scale testing (Phase 3)Study completedNCT02728752
What this trial is testing

Study Evaluating Efficacy and Safety of Octagam 10% in Patients With Dermatomyositis (Idiopathic Inflammatory Myopathy)

Who this might be right for
Dermatomyositis
Octapharma 95
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06887738
What this trial is testing

Study of NM8074 in Patients with Dermatomyositis (DM)

Who this might be right for
Dermatomyositis
NovelMed Therapeutics 8
Load More Results